惠泰医疗 (688617)

APT Medical Inc.

KSH

Tags

MSCI Component StocksSSE 380 IndexSpecial Purpose Equipment ManufacturingSpecialized-Sophisticated-Distinctive-Innovative EnterprisesMid Cap GrowthMedical DevicesPharmaceuticals and HealthcareGuozheng Growth IndexFund Heavy PositionsEmerging Markets IndexHundred-Yuan StocksSTAR Market 50 IndexSTAR Market Biotechnology IndexHigh-Performing StocksMargin Trading and Securities LendingBidding TargetsNon-Cyclical StocksHigh Price-to-Book Ratio

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 14101.38
  • Circulating A-Shares(W): 14101.38
  • Earnings Per Share(RMB): 4.4200
  • Net Assets Per Share(RMB): 21.1952
  • Operating Revenue(W RMB): 186743.75
  • Total Profit(W RMB): 70575.15
  • **Net Profit Attributable to Parent(W RMB) **: 62330.38
  • Net Profit Growth Rate(%): 18.02
  • Weighted Return on Equity(%): 22.4100
  • Operating Cash Flow Per Share(RMB): 4.7940
  • Undistributed Profit Per Share(RMB): 14.8499
  • Capital Reserve Per Share(RMB): 4.9546

2. Main Business

The main business covers:

  • Research, development, production, and sales of electrophysiology and vascular interventional medical devices

3. Company Basic Information

  • Company Name: Shenzhen Hui Tai Medical Apparatus Co., Ltd.
  • Listing Date: 2021-01-07
  • Industry: Special Purpose Equipment Manufacturing
  • Address: Room 601, Building B, Tongfang Information Port, No. 11 Langshan Road, Songpingshan Community, Xili Street, Nanshan District, Shenzhen City, Guangdong Province
  • Website: https://www.aptmed.com.cn/
  • Company Profile: On October 24, 2019, Hui Tai Limited held a board meeting and agreed to convert Hui Tai Limited into a joint stock company as a whole, using September 30, 2019 as the reference date. On November 9, 2019, the issuer held the founding meeting and converted as a whole based on the net assets confirmed by the audit report issued by Lixin Certified Public Accountants. On November 21, 2019, the company obtained its business license and is mainly engaged in the research, development, production, and sales of medical devices.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shenzhen Mindray Technology Holding Co., Ltd. Corporate Legal Person 3250.82 23.05
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 645.68 4.58
3 Zhuhai Tongsheng Investment Partnership (Limited Partnership) Corporate Legal Person 491.00 3.48
4 E Fund SSE STAR Market 50 Index ETF Fund 305.76 2.17
5 ChinaAMC SSE STAR Market 50 Index ETF Fund 299.21 2.12
6 Huabao CSI Medical ETF Fund 241.96 1.72
7 E Fund Blue Chip Selected Mixed Securities Investment Fund Fund 190.01 1.35
8 Fullgoal Precision Medicine Flexible Allocation Mixed Securities Investment Fund Class A Fund 142.72 1.01
9 Harvest Emerging Industries Stock Securities Investment Fund Fund 115.96 0.82
10 Harvest Core Growth Mixed Securities Investment Fund Class A Fund 93.96 0.67

5. Concept Sectors

  • Margin Trading & Securities Lending
  • High Price-to-Book Ratio
  • Blue-chip Stock
  • Heavily Held by Funds
  • Acquisition Target
  • Hundred-Yuan Stock
  • MSCI Constituent
  • Specialized, Refined, Peculiar and New Enterprises
  • Non-Cyclical Stock
  • SSE 380 Index
  • Mid-Cap Growth
  • SZSE Growth Index
  • STAR Market 50
  • STAR Market Bio-health
  • SZSE Emerging Composite Index

Remarks

  • Data update date: 2025-11-05
  • Data source: Public Market Information